awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37060855-8127B21D-9D77-4DCC-BA9B-C4CEA9BFECD8
Q37060855-8127B21D-9D77-4DCC-BA9B-C4CEA9BFECD8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37060855-8127B21D-9D77-4DCC-BA9B-C4CEA9BFECD8
Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: A subgroup analysis of five randomized clinical trials.
P2860
Q37060855-8127B21D-9D77-4DCC-BA9B-C4CEA9BFECD8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37060855-8127B21D-9D77-4DCC-BA9B-C4CEA9BFECD8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
27670a967e93b0cc32ecfae73af6c620e73e994e
P2860
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus